93 related articles for article (PubMed ID: 720073)
1. Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels.
Nash HA; Robertson DN; Jackanicz TM
Contraception; 1978 Oct; 18(4):395-409. PubMed ID: 720073
[TBL] [Abstract][Full Text] [Related]
2. Steroid release from silastic capsules and rods.
Nash HA; Robertson DN; Moo Young AJ; Atkinson LE
Contraception; 1978 Oct; 18(4):367-94. PubMed ID: 720072
[No Abstract] [Full Text] [Related]
3. Intravaginal contraception with the synthetic progestin, R2010.
Toivonen J
Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial with subdermal implants containing norgestrienone.
Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
[TBL] [Abstract][Full Text] [Related]
5. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
Da Silva AR; Coutinho EM
Int J Fertil; 1978; 23(3):185-92. PubMed ID: 40892
[TBL] [Abstract][Full Text] [Related]
6. Contraception with long acting subdermal implants: I. An effective and acceptable modality in international clinical trials.
Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
Contraception; 1978 Oct; 18(4):315-33. PubMed ID: 363345
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
Bahgat MR; Atkinson LE
Contraception; 1977 Mar; 15(3):335-45. PubMed ID: 880812
[No Abstract] [Full Text] [Related]
8. The plasma concentration of a synthetic progestin, R 2323, released from polysilastic vaginal rings.
Viinikka L; Victor A; Jänne O; Raynaud JP
Contraception; 1975 Sep; 12(3):309-16. PubMed ID: 1164849
[No Abstract] [Full Text] [Related]
9. Contraceptive efficacy of once-weekly oral administration of 2.5 mg R 2323.
Sakiz E; Azadian-Boulanger G; Ojasoo T; Laraque F
Contraception; 1976 Sep; 14(3):275-84. PubMed ID: 975818
[No Abstract] [Full Text] [Related]
10. Long acting contraceptive implants. An analysis of menstrual bleeding patterns.
Faundes A; Sivin I; Stern J
Contraception; 1978 Oct; 18(4):355-65. PubMed ID: 363347
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
12. First year clinical experience with six levonorgestrel rods as subdermal contraception.
Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
[TBL] [Abstract][Full Text] [Related]
14. A new delivery system for contraceptive steroids.
Segal S
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
[TBL] [Abstract][Full Text] [Related]
15. The NORPLANT contraceptive method: a report on three years of use.
Sivin I; Alvarez-Sanchez F; Diaz S; McDonald O; Holma P; Coutinho E; Robertson DN
Stud Fam Plann; 1982; 13(8-9):258-61. PubMed ID: 6814021
[No Abstract] [Full Text] [Related]
16. Clinical experience with implant contraception.
Coutinho E
Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
Kuhnz W
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2120-7. PubMed ID: 2124087
[TBL] [Abstract][Full Text] [Related]
18. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
19. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
Benagiano G; Ermini M; Carenza L; Donini P
Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
[TBL] [Abstract][Full Text] [Related]
20. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
